IDBI Capital research reports

• investments

Acutaas Chemicals is a High Quality Growth Pick. Buy for target price of ₹2141 (20% upside): IDBI Capital

Arjun October 25, 2025 0

The growth will be propelled by strong growth in the advanced pharma intermediates business

Read More

• investments

Top 15 companies from the NSE 500 basket that provide higher dividend yields by IDBI Capital

Arjun September 2, 2025 1

Here are the top 15 companies from the NSE 500 basket that provide higher...

Read More

• investments

Cummins India delivered robust performance in Q1FY26 which surpassed estimates. Buy for target price of ₹4401 (20% upside): IDBI Capital

Arjun August 8, 2025 0

Cummins India (KKC) delivered robust performance in Q1FY26 which surpassed our estimates. Revenue, EBITDA...

Read More

• investments

Top 15 companies from the NSE 500 basket that provide higher dividend yields of up to 9.3% by IDBI Capital

Arjun August 4, 2025 0

Here are the top 15 companies from the NSE 500 basket that provide higher...

Read More

• investments

Mold-Tek Packaging is poised for PER re-rating post robust earnings growth. Buy for target price of ₹906 (19% upside): IDBI Capital

Arjun July 29, 2025 0

We believe MPL is poised for PER re-rating post robust earnings growth for consecutive...

Read More

• investments

Apeejay Surrendra Park Hotels has a strong operating track record of high occupancy. Buy for target price of ₹214 (39% upside): IDBI Capital

Arjun May 31, 2025 0

Geographic expansion bodes well for future growth, BUY with a TP of Rs214: ASPHL...

Read More